Abbott Rapid Dx North America, LLC

NAICS
325412 Pharmaceutical Preparation ManufacturingThis U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Learn more at the U.S. Census Bureau
Name | Role | Address |
---|---|---|
CT CORPORATION SYSTEM | Agent | 450 VETERANS MEMORIAL PARKWAY SUITE 7A, EAST PROVIDENCE, RI, 02914, USA |
Name | Role | Address |
---|---|---|
LOUIS MORRONE | MANAGER | 100 ABBOTT PARK RD, D367 AP6D (SALES TAX) ABBOTT PARK, IL 60046 USA |
BENJAMIN OOSTERBAAN | MANAGER | 100 ABBOTT PARK ROAD ABBOTT PARK, IL 60064 USA |
TARA KAESEBIER | MANAGER | 100 ABBOTT PARK ROAD ABBOTT PARK, IL 60064 USA |
Type | Date | Old Value | New Value |
---|---|---|---|
Name Change | 2019-11-18 | Alere North America, LLC | Abbott Rapid Dx North America, LLC |
Number | Name | File Date |
---|---|---|
202450766310 | Annual Report | 2024-04-11 |
202331679760 | Annual Report | 2023-03-25 |
202216919020 | Annual Report | 2022-05-05 |
202104900510 | Annual Report | 2021-11-09 |
202074289390 | Annual Report | 2020-11-12 |
Agency | Date | Program | Subprogram | Amount |
---|---|---|---|---|
Department of Health | 2022-02-01 | COVID-19 | Testing | 138931.2 |
Department of Health | 2021-11-02 | COVID-19 | Testing | 1005.05 |
Department of Health | 2021-10-29 | COVID-19 | Testing | 46232.3 |
Department of Health | 2021-10-28 | COVID-19 | Testing | 370863.45 |
Department of Health | 2021-10-26 | COVID-19 | Testing | 84424.2 |
This company hasn't received any reviews.
Date of last update: 03 Jun 2025
Sources: Rhode Island Department of State